US 10837016
Modulation of huntingtin expression
granted A61PA61P1/00A61P15/00
Quick answer
US patent 10837016 (Modulation of huntingtin expression) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P1/00, A61P15/00, A61P19/10, A61P21/02